Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
- PMID: 15947080
- DOI: 10.1056/NEJMoa051586
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
Abstract
The prior diagnosis of fatal astrocytoma in a 60-year-old man with Crohn's disease treated with natalizumab, a monoclonal antibody against alpha4 integrins, was reclassified as JC virus-related progressive multifocal leukoencephalopathy (PML). Analysis of frozen serum samples showed that JC virus DNA had appeared in the serum three months after the initiation of open-label natalizumab monotherapy and two months before the appearance of symptomatic PML. There was staining of the brain lesion for polyomavirus. This case report, along with two others, suggests that anti-alpha4-integrin therapy can result in JC virus-induced PML.
Copyright 2005 Massachusetts Medical Society.
Comment in
-
Patients at risk.N Engl J Med. 2005 Jul 28;353(4):417. doi: 10.1056/NEJMe058123. Epub 2005 Jun 9. N Engl J Med. 2005. PMID: 15947081 No abstract available.
-
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences.N Engl J Med. 2005 Jul 28;353(4):414-6. doi: 10.1056/NEJMe058122. Epub 2005 Jun 9. N Engl J Med. 2005. PMID: 15947082 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical